NCT02068586 2026-03-16
Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
Thomas Jefferson University
Phase 2 Active not recruiting
Clinical Trials
56 trialsNCT06714357 2025-12-17
VICTORIA
National Cancer Institute, Naples
Phase 2 Recruiting
NCT01552434 2025-10-14
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT05821556 2025-07-29
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
National Cancer Institute, Naples
Phase 2 Recruiting
NCT06199557 2025-06-29
HUVAMER
Haukeland University Hospital
Phase 1/2 Recruiting
NCT03357757 2025-06-26
LATENT
AHS Cancer Control Alberta
Phase 2 Completed
NCT03048084 2025-02-04
STING
Leiden University Medical Center
Phase 4 Recruiting
NCT01817751 2024-07-17
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Virginia Commonwealth University
Phase 2 Completed
NCT02624128 2023-11-13
V-CHANCE
National Cancer Institute, Naples
Phase 2 Unknown
NCT04310176 2023-11-13
REVOLUTION
National Cancer Institute, Naples
Phase 2 Unknown
NCT01898104 2023-03-24
V-shoRT-R3
National Cancer Institute, Naples
Phase 1/2 Unknown
NCT03243461 2022-06-06
HIT-HGG-2013
University of Göttingen
Phase 3 Unknown
NCT01738815 2021-10-22
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
State University of New York - Upstate Medical University
Phase EARLY_PHASE1 Completed
NCT00879437 2021-07-21
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma
Baylor College of Medicine
Phase 2 Completed
NCT03885947 2021-05-24
VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
Icahn School of Medicine at Mount Sinai
Phase 1 Completed
NCT02124174 2021-04-26
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
Loyola University
Phase 2 Unknown
NCT00181220 2020-05-18
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
Johns Hopkins University
Phase 1 Withdrawn
NCT01900730 2020-02-25
Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02520115 2019-08-14
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00414310 2019-05-21
Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00075010 2018-11-15
Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT00670046 2018-09-28
Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT01106872 2018-08-10
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
University of Iowa
Phase 1 Completed
NCT00854581 2018-04-17
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
University of Miami
Phase 4 Terminated
NCT01622439 2018-03-12
VALFRID
Lund University Hospital
Phase 1/2 Completed
NCT02608736 2018-02-01
GAMA
Barretos Cancer Hospital
Phase EARLY_PHASE1 Completed
NCT02648633 2017-05-31
Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
University of Virginia
Phase 1 Terminated
NCT02144623 2017-03-03
PREVAIL
Lund University Hospital
Phase EARLY_PHASE1 Completed
NCT00246103 2017-02-23
Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00437957 2017-02-23
Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Terminated
NCT01204450 2016-12-23
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
UNC Lineberger Comprehensive Cancer Center
Phase 1 Terminated
NCT00867672 2016-08-31
DECIDER
University Hospital Freiburg
Phase 2 Completed
NCT01007695 2016-07-20
VAST
University of Utah
Phase 1 Terminated
NCT02761291 2016-05-16
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Chang Gung Memorial Hospital
Phase 1 Unknown
NCT01695122 2016-02-23
Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
Instituto do Cancer do Estado de São Paulo
Phase 2 Completed
NCT00996060 2016-01-18
Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies
New Mexico Cancer Research Alliance
Phase 1 Completed
NCT00175812 2015-06-24
Differentiation Induction in Acute Myelogenous Leukemia
University of Bergen
Phase 1/2 Completed
NCT00995332 2015-06-24
Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine
University of Bergen
Phase 1/2 Completed
NCT01369368 2015-06-24
Treatment of Acute Leukemia Relapse After Allotransplantation
University of Bergen
Phase 1/2 Unknown
NCT01861990 2015-05-22
Valproic Acid in Childhood Progressive Brain Tumors
Medical University of South Carolina
Phase 1 Withdrawn
NCT02446431 2015-05-18
Metronomic
Miller Children's & Women's Hospital Long Beach
Phase EARLY_PHASE1 Recruiting
NCT00634205 2015-02-12
Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma
European Lung Cancer Working Party
Phase 2 Completed
NCT00525135 2015-02-03
Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
University of California, San Francisco
Phase 2 Terminated
NCT00530907 2015-01-08
Valproic Acid and Bevacizumab in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00358319 2013-11-25
Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Terminated
NCT00529022 2013-02-20
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00495872 2012-10-18
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00513162 2012-09-19
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00382590 2012-08-07
Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00496444 2012-08-01
Azacytidine and Valproic Acid in Patients With Advanced Cancers
M.D. Anderson Cancer Center
Phase 1 Completed